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ABSTRACT

Cisplatin is an important anti-cancer drug. Structurally, cisplatin is a coordination
complex, which means that it has a central metallic atom: platinum. Side interactions
prevent cisplatin from effectively treating cancerous cells by reaction with DNA.
Cisplatin has a high rate of forming protein adducts, primarily with sulfur containing
amino acids. To better understand how cisplatin interacts with sulfur containing amino
acids in the body, a platinum compound with an ethylenediamine ligand attached was
reacted with N-acetylcysteine and glutathione. The reactions of cysteine with platinum
were performed at three pH values: 7.0, 8.5, and 10. NMR spectroscopy was used to
examine these reaction over time. A COSY and HMQC spectrum of glutathione’s
reaction with platinum were collected to better identify the reaction products. All 1H
NMR spectra were taken on a JOEL Eclipse 500 MHz NMR instrument. The appearance
of a free ethylenediamine ligand signal, in many cases, suggests that the amino acids
react to form products in which the ethylenediamine ligand is displaced as the amino
acids react via both sulfur and nitrogen atoms.

Keywords: Cisplatin, ethylenediamine ligand, N-acetylcysteine, glutathione, NMR
spectroscopy
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CHAPTER 1

INTRODUCTION

The importance of cisplatin as an anti-cancer drug justifies it as a prime research
topic. It is particularly effective in treating testicular and ovarian cancers. Although
cisplatin is effective in treating specific types of cancer, it causes many serious side
effects. The main side effects cause by cisplatin include nephrotoxicity, neurotoxicity,
ototoxicity, nausea, and vomiting (O’Dwyer 1999).
Because cisplatin has a high rate of forming protein adducts, it is not only
ineffectively absorbed into cells, but it is also less effective at actually targeting
cancerous DNA. Curtailing protein adduct formation will make cisplatin much more
effective at targeting cancerous DNA; however, this will require a thorough
understanding of how cisplatin behaves in the body. Hopefully my research will be a
small piece to this puzzle, and allow the scientific community to better understand
cisplatin’s overall behavior.
Cisplatin is a coordination complex, meaning that it has a central metallic atom.
The central metallic atom in cisplatin is platinum.
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Figure 1.1: Cisplatin
Cisplatin works by cross-linking with cancerous DNA. When cisplatin cross-links
with DNA it prevents the DNA from being replicated and results in cell apoptosis.
Although cisplatin most commonly forms either intra-strand cross-links or inter-strand
cross-links DNA adducts, intra-strand cross-links are more effective at damaging
cancerous cells. This is because the DNA is poorly repaired (Coluccia and Natile 2007).
Fortunately, the preferred DNA adduct formed by cisplatin is intra-stranded cross-links,
which occurs about 65% of the time (Eastman 1999).
Cross-links occur particularly at guanine residues. Because other macromolecules
in the body, and within individual cells can interact with cisplatin, its effectiveness at
strictly targeting cancerous DNA is limited. Studies have shown that within 1 day of
administering cisplatin intravenously, a shocking 65-98% of cisplatin is bound to proteins
(DeConti et al. 1973).
Cisplatin is prone to interacting with proteins, particularly sulfur containing
amino acids. Cisplatin has an especially high affinity towards proteins with cysteine and
methionine residues because they are the two amino acids that contain sulfur. Cisplatin’s
interactions with proteins interferes with the drug’s ability to cross-link with DNA, and
this affects its ability to cause apoptosis in cancerous cells. It has been suggested that the
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protein adducts are what causes the drug’s harsh side effects and resistance to the drug
(Kartalou and Essigmann 2001; Reedijk 1999).

Figure 1.2: Cisplatin reacts with N(7) of guanine

Figure 1.3: Cisplatin forms intra-strand cross-links: DNA poorly repaired

Figure 1.4: Trans-platinum forms inter-stand cross-links:
DNA repaired more efficiently
Initially, my research looked at how platinum interacted with N-acetylcysteine
(N-AcCys) over time. Because cisplatin has a central metallic atom of platinum that is
primarily involved in interactions with other atoms, I specifically studied how platinum
interacted with N-AcCys. I also looked at how N-AcCys’s interaction with platinum was

3

affected by altering the pH of the environment in which the reaction took place. The pH
was altered to 7, 8.5, and 10 because the thiol group of N-AcCys has a pKa of ~8.5.

Figure 1.5: N-acetylcysteine
Next, I transitioned to looking at how platinum interacted with glutathione (GSH).
GSH is synthesized in most cells within the body, and is a tripeptide, which contains the
amino acids glutamate, cysteine and glycine. Larger molecules such as GSH have NMR
spectra with many peaks that are harder to decode. It was necessary to perform
correlation spectroscopy (COSY) and heteronuclear single quantum coherence
spectroscopy (HMQC) to help clarify molecular changes in the GSH samples.
In conclusion, because cisplatin has a central metallic atom of platinum that is
primarily involved in interactions with other atoms, I specifically studied how platinum
interacted with cysteine residues, both free cysteine resides and cysteine in GSH. My
work with platinum interacting with GSH can be compared to my results from cysteine’s
interaction with platinum. Studying these reactions will further advance the scientific
communities’ understanding of how cisplatin potentially reacts within the body.
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Figure 1.6: Reduced Glutathione
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CHAPTER 2

METHODS

Synthesis of Platinum Compounds
Silver oxalate was prepared by mixing equal molar amounts of oxalic acid and
silver nitrate in water. The reaction was stirred for several hours in an amber vial, and the
insoluble silver oxalate was collected by vacuum filtration and rinsed with water.
Dichloro(ethylenediamine)platinum(II) (Pt(en)Cl2) was reacted with an equimolar
amount of either silver nitrate or silver oxalate and the reaction was stirred in an amber
vial overnight. The sample was filtered to remove the insoluble silver chloride, and the
water was removed using a rotary evaporator (rotavap) with heating to leave either
Pt(en)(NO3)2 or Pt(en)(ox), respectively.
NMR Spectroscopy
My research project relied on nuclear magnetic resonance (NMR). NMR utilizes a
powerful magnet to analyze a sample and it produces a spectrum with peaks. All 1H
NMR spectra were taken on a JOEL Eclipse 500 MHz NMR instrument. The chemical
shift of these peaks was determined in reference to deuterium oxide as a secondary
reference. These spectrums are also used to identify what interactions are occurring
within a given sample.
In general, samples were prepared by weighing out a specific amount of a sample
in milligrams, and then adding 1 milliliter of deuterium oxide to that sample in a NMR
6

tube. The samples with only N-AcCys were prepared with 1.6 mg of N-AcCys. All three
samples of N-AcCys and Pt at ~ pH of 7, 8.5, and 10 were made with 1.6 mg of NAcCys, 1.7 mg of Pt(en)(ox), and 1 milliliter of deuterium oxide. A vortex was used to
help dissolve the samples into the solution of deuterium oxide. The desired pH of each
sample was achieved by adding either sodium deuteroxide to raise the pH, or nitric acid
in deuterium oxide to lower the pH. These tubes were then labeled, and their contents are
analyzed by NMR spectroscopy. To follow up, I checked samples again either after 24
hours and/or after 1 week to track a sample’s reaction progress.
Both the reduced and oxidized samples of GSH were made with 3.0 mg of GSH
dissolved in 1 milliliter of deuterium oxide. Another sample of reduced GSH was made
with 20 mg for COSY and HMQC analysis. To emulate a 1 to 1 molar ratio a sample of
1.9 mg of Pt(en)(NO3)2 and 3.1 mg of reduced GSH was created. A sample of 6.2 mg of
reduced GSH and 3.8 mg of Pt(en)(NO3)2 was also created.
COSY
COSY is a form of 2-dimensional spectroscopy. Peaks that appear on the diagonal
are the connected peaks seen in the 1-dimensional NMR. Cross-peaks are the peaks that
appear to the sides of the diagonal peaks. Cross-peaks represent protons that are
connected with other protons at least one carbon bond apart. A COSY was taken on the
sample of 20 mg of reduced GSH and on the sample of 1.9 mg of Pt(en)(NO3)2 and 3.1
mg of GSH.
HMQC
HMQC is also a 2-dimensional spectroscopy that plots molecules against a carbon
and hydrogen axis. The produced spectrum has a peak for every unique proton that is
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attached to a molecule’s carbons. Magnetization is transferred from a molecule’s
hydrogens and carbons in a back-and-forth manner and signals are recorded at
incremental times. Hydrogen signals are measured and recorded directly, and the
chemical shift of carbon is measured and recorded secondarily. The series of experiments
from multiple time increments established the dimensions formed by carbon atoms. A
HMQC was taken on the sample of 20 mg of reduced GSH and on the sample of 1.9 mg
of Pt(en)(NO3)2 and 3.1 mg of GSH.
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CHAPTER 3

RESULTS

Part 1: N-acetylcysteine and Pt at ~ pH of 7, 8.5, and 10
Figure 3.1 shows the NMR of N-AcCys at pH ~ 7 with no Pt(en)(ox). The peak at
1.9 ppm represents the methyl H’s of the acetyl group, the peak at 2.75 ppm represents
the CH2 group, and the peak at 4.2 ppm represents the α-H. After 24 hours the sample
was analyzed once again by NMR. The two NMR figures show very few differences;
thus, very little air oxidation of N-AcCys was seen. This suggests that air oxidation of NAcCys is a slow process, and should not be a major factor in altering the chemical
structure of N-AcCys at a pH of 7. The two NMR readings of N-AcCys at pH ~ 7 can be
used as a baseline to better understand what occurs when N-AcCys reacts with
Pt(en)(ox).
Following the same procedures, another sample was made with a pH of 7.
Pt(en)(ox) was added to this sample of N-AcCys. Figure 3.2 shows N-AcCys and
Pt(en)(ox) at pH ~ 7. Comparing figure 3.2 to figure 3.1, both at 30 minutes, reveals that
the only new peak is at 2.35 and that this new peak must be from the ethylenediamine
(en) ligand attached to platinum. As previously indicated the other peaks at 1.9 ppm, 2.75
ppm, and 4.2 ppm represents the methyl H’s of the acetyl group, the CH2 group, and the
α-H respectively.
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After 24 hours the reaction between N-AcCys and platinum produces a new
product. After 24 hours the peak at 2.35 ppm, which represented the sample of unreacted
platinum (ox) has significantly diminished and a new peak at 3.2 ppm has appeared. This
new peak represents the ethylenediamine (en) ligand when it is not connected to platinum
(ox).
The mechanisim for the reaction that results in the en ligand being discociated can
be explained by previous research. When Pt(en)(ox) is reacted with N-AcCys, the sulfur
atom of a N-AcCys groups binds to platinum. This process can eventually result in two
N-AcCys groups being bound to Pt(ox) when enough N-AcCys is available. Next, to gain
stability, Pt(ox) undergoes chelation, and in this process the en ligand is dissociated
(Williams et al. 2011).
After one week, the peak at 2.35 ppm has completely disappeared, and the peak
at 3.2 ppm has become even more noticeable. This signals that after one week the
reaction of N-AcCys and platinum is complete. It appears that all of the en ligand has
dissociated from platinum (ox). New peaks at 3.1 ppm signal that oxidation has begun to
occur.
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Figure 3.1: N-acetylcysteine at pH ~ 7

11

Figure 3.2: N-acetylcysteine and platinum at pH ~ 7
In figure 3.3 a sample of N-AcCys and platinum (ox) at pH ~ 8.5 was used. The
figures were similar to those of N-AcCys and platinum (ox) at pH ~ 7. The only notable
difference was that the peaks were smaller and chelation of platinum (ox) by cysteine
occurred at a slower rate.
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Figure 3.3: N-acetylcysteine at pH ~ 8.5
The third group of samples involved N-AcCyss and platinum at pH ~ 10. Figure
3.4 shows N-AcCys without platinum (ox) at pH ~ 10. Comparing figure 3.4 to figure 3.1
shows that the peak at 4.2 ppm did not materialize.
This is the peak that represents the α-H of N-AcCys. Like in figure 3.1, the peak
at 1.9 ppm represents the methyl H’s of the acetyl group, and the peak at 2.75 ppm

13

represents the CH2 group. After one week significant oxidation was seen in the same
sample that initially produced figure 3.3.
Figure 3.5 shows N-AcCys and platinum (ox) at pH ~ 10 at time intervals of 30
minutes, 24 hours, and 1 week. At pH of ~ 10 the continued trend of smaller, less defined
peaks is observed. The chelation of platinum is still seen, but it is accompanied by
significant oxidation of the sample. The graphs prove that the reaction between N-AcCys
and platinum (ox) is the least efficient at pH ~ 10.

Figure 3.4: N-acetylcysteine at pH ~ 10
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Figure 3.5: N-acetylcysteine and platinum at pH ~ 10
Part II: Glutathione’s interaction with platinum
Before GSH’s NMRs could be analyzed, a COSY and HMQC was required to
help assign GSH’s NMR signals. The first COSY and HMQC was run on a sample of 20
mg of reduced GSH. This was done after an NMR of the sample was recorded. The peak
on the COSY at 2.0 ppm was assigned to glutamate’s β hydrogens, because it was the
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only group to be coupled with two cross-peaks at 2.4 and 3.6 ppm. This indicated that
glutamate’s β hydrogens were in the middle of the two groups it was coupled with:
glutamte’s α and γ hydrogens.
The γ hydrogens of glutamate were downfield by cysteine’s thiol group and
appeared on the COSY at 2.4 ppm. The β hydrogens of cysteine were further downfield
because of their connection to a thiol group. This peak appeared at 2.75 ppm on the
COSY. The α hydrogen of glutamate appeared on the COSY at 3.65 ppm. The α
hydrogens of glycine appeared at 3.8 ppm on the COSY and were the only signals to
leave no cross-peaks. The α hydrogen of cysteine appeared on the COSY the furthest
downfield at 4.4 ppm because of its proximity to thiol.

Figure 3.6: 20 mg reduced glutathione
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Figure 3.7: COSY 20 mg reduced glutathione

Figure 3.8: HMQC 20 mg reduced glutathione
After reduced GSH’s peaks had been identified, the NMRs produced for both
reduced and oxidized GSH could be analyzed. The purpose of these two NMRs was to
have an idea of what reduced GSH and oxidized GSH looked like before they reacted
with platinum. In addition, it was important to examine the two samples after two weeks
to see how air oxidation altered their appearances. Oxidized and reduced GSH’s NMRs
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are shown in figure 3.9. The results from the COSY and HMQC helped identify the peaks
seen on reduced and oxidized GSH’s NMRs.
In oxidized GSH the peak at 4.55 ppm represents glutamate’s β-H, the peak at 4.9
ppm represents γ-H of glutamate, the peak at 5.3 ppm represents β-H of cysteine, the
peak at 5.65 ppm represents the α-H of cysteine, the peak at 6.2 ppm represents α-H of
glutamate, and the peak at 6.35 ppm represents α-H of glycine.
In reduced GSH the peak at 4.55 ppm represents glutamate’s β-H, the peak at 4.9
ppm represents the γ-H of glutamate, the peak at 5.3 ppm represents the β-H of cysteine,
the peak at 6.2 ppm represents the α-H of glutamate, the peak at 6.4 ppm represents the αH of glycine, and the peak at 6.95 ppm represents the α-H of cysteine.

Figure 3.9: 3 mg reduced and oxidized glutathione
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When Pt(en)(NO3)2 was added to reduced GSH, the NMR initially looked
relatively similar to the NMR with only GSH. After one week the peak at 6.4 ppm,
signaling α-H of glycine, was reduced and a new peak emerged at 3.2 ppm. The signals at
4.55 ppm, 4.9 ppm, and 5.3 ppm also diminished in signal strength. This new peak
represented a slow, but immediate start to the dissociation of the en ligand.

Figure 3.10: 6.2 mg GSH and 3.8 mg Pt
When 1.9 mg of Pt(en)(NO3)2 was added to 3.1 mg of reduced GSH the NMRproduced, broad-based peaks (figure 3.11). This, combined with the complexity of GSH’s
structure, required the second COSY and HMQC to clarify the reaction taking place
between GSH and Pt(en)(NO3)2.
19

Figure 3.11: 1.9 mg Pt(en)(NO3)2 and 3.1mg GSH

Figure 3.12: COSY 1.9 mg Pt(en)(NO3)2 and 3.1 mg GSH

Figure 3.13: HMQC 1.9 mg Pt(en)(NO3)2 and 3.1 mg GSH
20

CHAPTER 4

DISCUSSION
Cysteine’s thiol group has a typical pKa value of about 8.5. As the pH of cysteine
approaches 8.5, the thiol group is deprotonated. The pKa of cysteine’s carboxylic acid
group is around 2 and the pKa of cysteine’s amino group is around 9. At a pH below 2
both the amino and carboxylic groups are protonated, giving the carboxylic group a
neutral charge and the amino group a positive charge. At a pH of 9 or above both groups
are deprotonated and this gives the amino group a neutral charge and the carboxylic
group a negative charge.
When the pH is between 2 and 9, cysteine exists in its zwitterionic form. In this
form, most similar to human physiological pH, the molecule has a neutral charge; the
amino group’s positive charge balances the carboxylic group’s negative charge. The
attachment of the acetyl group slightly alters the pKa characteristics of cysteine. Since the
experiments with N-acetyl cysteine at pH 7 and 8.5 yield virtually the same results, this
suggests that none of the molecule’s pKa values have been reached. Comparing the
results from the reaction of N-acetyl cysteine and platinum at a pH of 7 and 8.5 show that
a slightly higher pH causes platinum to react with N-acetyl cysteine’s thiol group more
slowly.
At pH 10 we see changes in the NMR spectrum. The peak at 4.2 ppm is not
present as in the previous two spectrums. The signal could have either moved under the
21

water signal or else air oxidation could have occurred. The reaction at pH 10 shows that
the chelation of N-acetyl cysteine occurs at a much slower pace.
GSH is a molecule abundant in most cells and it contains cysteine. Because of
GSH’s abundance in cells, it plays a big role in limiting cisplatin’s ability to bind to
DNA. The results show that the chelation of GSH’s cisplatin group occurs at no
noticeably slower speed than that of free cisplatin groups. This suggests that GSH’s
larger structure does not cause steric hindrance in this reaction.
Figure 4.1 shows the proposed reaction in which glutathione binds to platinum. At
the conclusion of this reaction the en ligand is displaced so the adduct can form an
additional chelate ring; having 2 chelate rings makes the adduct more stable.
In a previous study (Lempers et al. 1987) altering the pH of GSH and a platinum
complex showed that the 1H chemical shifts of cysteine are independent of pH ranging
from 4 through 10; however all other 1H peaks from glutamate and glycine were found to
be pH dependent. This suggests that the first ethylenediamine complex coordinates with
GSH’s sulfhydryl group across pH differences. Further experimentation revealed that the
second ethylenediamine complex also coordinates to the sulfhydryl group.
The study also found that at a pH below 7, the adduct moves to completion at a
very fast rate, as the second Pt-binding step occurs much faster than the first Pt-binding
step. This is perhaps why the GSH sample’s NMR only showed the complete product of
the reaction and why figures 3.10 and 3.11 show no intermediate products (Lempers et al.
1987).
The primary result of a 1:1 ratio of GSH and a platinum complex has previously
been found to produce 1 new peak within 1 hour. Additionally, this ratio produces a
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predictable sulfur-bridged product (Oehlsen et al. 2005). In figures 3.10 and 3.11, 1 week
resulted in 1 new peak, which suggests that only one sulfur-bridged product was
produced.
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Figure 4.1: Proposed reaction scheme of Pt(en)(NO3)2 with GSH
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